Register Now
Login to Partnering
Youtube Linkedin Facebook
McCormick Place Convention Center, Chicago, IL | July 30th - August 1st, 2024

DxPx U.S. 2024 Registration

Register Now and Join DxPx U.S.

Startups, Growth and Strategic companies in the Diagnostics, Digital Health, Precision Medicine, and Life Sciences Tools space come to DxPx to meet with potential investors, discover new technologies and network with their peers. Registration includes:

  • 3 days of in-person meetings in the heart of ADLM 2024, from July 30th – August 1st, 2024
  • Partnering Platform to schedule in-person meetings
  • Access to DxPx Startup City areas & panel discussions
  • Access to the ADLM 2024 Clinical Lab Expo

Select Your Registration Type

Startups

As Low as $499

Learn More & Register

Growth Companies

  • Extend your conference networking by attending our Private Equity Dinner
  • Benefit from pre-scheduled 1x1 meetings with private equity firms and other growth-stage investors

As Low as $1,499

Learn More & Register

Industry Companies

  • Meet some of the most exciting new companies in the industry
  • Enhance your reputation and visibility in the industry.
  • Take your tech scouting to the next level as a 42PLUS1 judge

As Low as $2,225

Learn More & Register

Investors

  • Attend DxPx U.S. for free by registering as a judge for our 42PLUS1 pitch competition
  • Meet your next co-investors & conduct technology scouting like never before​
  • Join our Ambassador Network to secure discounts for your portfolio companies

Free*

Learn More & Register

Accelerators/Incubators

DxPx-Conference-375-Web-1
  • Learn valuable industry insights
  • Get 20% off our standard pricing for registration, presentations, and booth space for up to five (5) of your portfolio companies
  • Grow your portfolio and find your next big opportunity

As Low as $1,499

Learn More & Register

Service Providers

  • Enhance your reputation and visibility in the industry
  • Access to valuable industry insights and research
  • Limited availability to ensure you maximize your visibility

As Low as $3,499

Learn More & Register
Checkout / View Cart

Date & Location:

July 30 – August 1, 2024 in Chicago, IL at the ADLM 2024 Clinical Lab Expo

McCormick Place Convention Center
2301 South King Dr., Chicago, IL 60616

Don't miss our investor conferences & early-stage investing events:

dxpx us adlm logos
DxPx US

DxPx Industry & Investor Conference US:
4 Days In-Person

July 29 - Aug. 1, 2024
Chicago, IL
In the ADLM

Stay up to date and sign up for our latest news:

Next: DxPx U.S. 2025
  • 3 Days In-Person
  • July 29 - 31, 2025
  • McCormick Place
    Convention Center
    Chicago, Illinois, USA
Next: DxPx EU 2026
  • 2 Days In-Person
  • Reception: February 5, 2026
    Partnering Day & 42PLUS1:
    February 6, 2026
  • Munich, Germany
Download Brochure
DxPx media
Useful links

© Copyright DxPx 2025. All Rights Reserved.

Youtube Linkedin Facebook

Oliver Dick

Oliver brings 30+ years of experience in the life sciences industry, has worked in pharma, biotechnology and in vitro diagnostics. His areas of expertise fall under Supply Chain Management, Planning, Production, QC, QA, Engineering, Technology Transfer and Process Improvement. Amongst his vast experience, Oliver held functions such as Vice President of Global Manufacturing at QIAGEN, Chief Operating Officer at Miltenyi Biotec or Chief Operating Office of Resolve Biosciences. He demonstrated exceptional leadership and expertise in driving manufacturing excellence on a global scale.

Oliver has a proven ability to streamline processes, optimize production efficiency, and foster a culture of innovation. He was responsible for strategy development, scaling, cost control and quality and was part of multiple M&A projects and transfer of many new products from acquisition or own development. Today Oliver offers his expertise mainly through his own Consultancy Service Company ODICON.

Experience

Christoph Brandenberger

Christoph Brandenberger is a Managing Director at BGL and a leader in the firm’s Diagnostics, Research Tools & Medical Devices investment banking group. He has more than 20 years of experience in all aspects of mergers and acquisitions, commercialization and partnering agreements, and private placements.

A native of Austria and fluent in German, Christoph’s investment banking experience, coupled with his background in international business, has made him a sought-after advisor in both the domestic and international healthcare markets.

Prior to joining BGL, Christoph served as managing director for Healthios Capital Markets, LLC. Christoph started his career as a financial analyst for Bank of America Securities.

Experience

John Riddle

John Riddle is a Managing Director and member of the BGL Executive Committee. He has more than 30 years of investment banking and capital markets experience, advising clients across a broad spectrum of mergers and acquisitions, capital markets activities, and strategic assignments.

John leads BGL’s advisory activities in the Healthcare & Life Sciences investment banking group, which comprises both corporate investment banking and real estate capital markets capabilities. Together with his team, John maintains an ongoing coverage effort with broad activity across several sectors, including health facilities, physician services, and ancillary providers; diagnostics and research tools; medical device and products; and select healthcare technology verticals, including payor services, data analytics, and clinical automation.

Experience

Dr. Mirko Stange

Born in Bremen, Germany in 1974, Dr. Mirko Stange is a diagnostics and life sciences expert with a proven track record in turning around and commercializing innovations. He possesses extensive executive management experience, having led diagnostics and biotech startups, as well as developing and conducting consulting products. Following the completion of his Ph.D. in Biochemistry and Biophysics at the University of North Carolina at Chapel Hill, Dr. Stange began his career in 2004 at the strategy consultancy McKinsey. Subsequently, he worked with the turnaround-specialized advisory firm Droege & Comp., primarily serving clients from the pharma and chemistry industry in Germany and Switzerland.

In 2008, he founded an independent Life Sciences consultancy in Germany where, to date, he leads and directs a team of international experts. This team identifies and funds SMEs with high potential for national and international leverage. In addition to his over ten years of experience in independent corporate finance and management consulting, Mirko Stange provides interim management services to selected clients. To date, three companies co-founded and managed/advised by Dr. Stange have been successfully exited. Leveraging his scientific background, he is also a named inventor on several granted and pending patents.

Experience

FName LName

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Experience